BVMed changes name to broaden its influence:
This article was originally published in Clinica
Executive Summary
In an effort to broaden its appeal to industry, the German medical devices industry association (BVMed) has changed its name from Bundesfachverband Medizinprodukteindustrie (Federal Association of the Medical Device Industry in Germany) to Bundesverband Medizintechnologie (German Medical Technology Association). The transition allows the association to retain the BVMed acronym. The decision to change its name was agreed upon at BVMed's general assembly at the end of September in Berlin, but has only now been entered into the official register of associations. Joachim Schmitt, director general of BVMed said: "With the new name and new statutes, BVMed is open for new fields of business and action."
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.